Last update:

Clinical pharmacology news

One-time gene editing treatment lowers 'bad' cholesterol by up to 62%

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, as part of a study involving UCL scientists.

Influencers are promoting dangerous peptides on social media, and regulators are struggling to keep up

Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers—and regulators struggling to keep up.